Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Regulatory Status Retatrutide is an investigational drug and has not been approved by the FDA for any use, including weight management during menopause
By mimicking naturally occurring hormones involved in appetite and glucose regulation, it may help individuals feel fuller for longer, stabilize cravings, and experience balanced energy levels
We help you stand out, convert more leads, and scale your practice sustainably
In a family medicine setting, clinicians can use this approval as an opportunity to re-engage patients who previously declined GLP-1 treatment due to injection aversion, opening a new conversation about metabolic and weight management goals
After cessation of diazoxide treatment due to progression, 30% rebound responses were observed in animals that had a first remission due to diazoxide
US$ 26.27
US$ 26.26
US$ 29.71
